Papers: 10.3390/ijms20020429

https://doi.org/10.3390/ijms20020429

BAP1 Status Determines the Sensitivity of Malignant Mesothelioma Cells to Gemcitabine Treatment

Cited by: 38
Author(s): Alice Guazzelli, Parisa Meysami, Emyr Bakker, Constantinos Demonacos, Antonio Giordano, Marija Krstic‐Demonacos, Luciano Mutti
Published: over 7 years ago

Software Mentions 1